ClinicalTrials.Veeva

Menu
S

Skin Search of Rochester | Rochester, NY

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

M518101
Amlitelimab
Glycopyrronium
NFX-179
MT10109L
NAFT-600
Ruxolitinib
MOB015B
SHR0302
Enbrel

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 51 total trials

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

The primary objective of the study is to evaluate the safety of IMG-007 in adults with Alopecia Areata.

Active, not recruiting
Alopecia Areata (AA)
Drug: IMG-007

This is a Phase 2, multicenter, randomized, double-blind placebo controlled, 2-arm study to evaluate the effect of amlitelimab on vaccine antibody re...

Enrolling
Dermatitis Atopic
Drug: Amlitelimab
Biological: Tdap vaccine

This is a Phase 3 multicenter, double-blind study to evaluate the safety and efficacy of vehicle-controlled topical MOB015B in the treatment of Dista...

Active, not recruiting
Onychomycosis
Drug: MOB015B
Drug: Vehicle (Placebo Comparator)

This is a single group, Phase 2/3, long-term extension study for treatment. The purpose of this study is to characterize the safety and efficacy of a...

Enrolling
Dermatitis Atopic
Drug: Oral corticosteroids
Drug: Amlitelimab

The aim of this study is to test the safety and efficacy of photodynamic therapy (PDT) for the medication Ameluz® performed with the PDT-lamp BF-Rhod...

Enrolling
Acne Vulgaris
Combination Product: 1h Incubation Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)
Combination Product: 3h Incubation Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)

The aim of this study is to test the safety and efficacy of photodynamic therapy (PDT) with the medication Ameluz® performed with the PDT-lamp BF-Rho...

Active, not recruiting
Superficial Basal Cell Carcinoma
Combination Product: Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)
Combination Product: Placebo Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)

The aim of this study is to test the safety. tolerability and efficacy of field-directed photodynamic therapy (PDT) with 10% aminolevulinic acid gel...

Enrolling
Actinic Keratoses
Combination Product: BF-200 ALA and red light LED lamp
Combination Product: Vehicle and red light LED lamp
Locations recently updated

The purpose of the study is to evaluate the effect of ruxolitinib cream on sleep disturbances with participants with Atopic Dermatitis.

Enrolling
Atopic Dermatitis
Drug: ruxolitinib cream

Trial sponsors

B
Allergan logo
D
LEO Pharma logo
Pfizer logo
J
Medytox logo
N
Sanofi logo
Sol-Gel Technologies logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems